Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024)

Nyxoah's (NYXH) quarterly Income from Non-Controlling Interests came in at $594.1 million in Q4 2024, up 1515.91% year-on-year from $36.8 million in Q1 2024, and up 1515.91% quarter-over-quarter from -$42.0 million in Q4 2023.

Nyxoah (NYXH) Income from Non-Controlling Interests (2021 - 2024) Analysis & Trends

Nyxoah's Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $594.1 million for Q4 2024.

  • On a quarterly basis, Income from Non-Controlling Interests rose 1515.91% year-over-year to $594.1 million in Q4 2024; TTM through Dec 2024 was $637.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at $830.3 million, up 2078.71% from the prior year.
  • Income from Non-Controlling Interests grew to $594.1 million in Q4 2024 per NYXH's latest filing, from -$42.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $594.1 million in Q4 2024 and bottomed at -$42.0 million in Q4 2023.
  • The 4-year median for Income from Non-Controlling Interests is $42.5 million (2022), against an average of $159.3 million.
  • Across the five-year window, Income from Non-Controlling Interests sank 242.74% in 2023 and soared 1515.91% in 2024, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $97.2 million in 2021, then sank by 112.59% to -$12.2 million in 2022, then sank by 242.74% to -$42.0 million in 2023, then surged by 1515.91% to $594.1 million in 2024.
  • Per Business Quant, the three latest NYXH Income from Non-Controlling Interests figures stand at $594.1 million (Q4 2024), -$42.0 million (Q4 2023), and -$12.2 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn -18.70 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn -
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 110.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn -
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn -
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn -
10 Nyxoah 53.92 Mn 100.91 Mn 4.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 594.14 Mn
Dec 31, 2023 -41.96 Mn
Dec 31, 2022 -12.24 Mn
Dec 31, 2021 97.24 Mn